The leaders of Zhangjiang High-tech Zone Management Committee and Municipal Education Commission visited our company for research

On the afternoon of May 4, Cao Zhenquan, executive deputy director, Zhu Aicun, Cai Wusan, Li Lijun, inspector Jiang Hong, Xu Kaiyu, and Lu Zhen of Shanghai Municipal Education Commission visited our company to carry out the project research of "Antibody and vaccine biomanufacturing technology application service platform and raw material and equipment localization pilot base construction". The research activities were also attended by Mr. Zhu Anda, President of Shanghai Zhangjiang University Collaborative Innovation Institute, Mr. Ni Qiji, Vice President of East China University of Science and Technology, and Mr. Zhang Yanduo, Chairman of Huali Asset Management Co.

Prof. Tan Wensong, the chairman of BioEngine and the project leader, made a brief report on the construction of the project "Antibody and vaccine biomanufacturing technology application service platform and raw materials and equipment localization pilot base construction (Phase I)". The research activities were also attended by Mr. Zhu Anda, President of Shanghai Zhangjiang University Collaborative Innovation Institute, Mr. Ni Qiji, Vice President of East China University of Science and Technology, and Mr. Zhang Yanduo, Chairman of Huali Asset Management Co. Prof. Tan Wensong, the chairman of BioEngine and the project leader, made a brief report on the construction of the project "Antibody and vaccine biomanufacturing technology application service platform and raw materials and equipment localization pilot base construction (Phase I)". Relying on East China University of Science and Technology, the company has built the first domestic R&D and application service platform for antibody and vaccine pilot incubation and industrialization of key technology innovation, implemented localization of key raw materials and equipment, and set industry standards for antibody vaccine and key raw materials and equipment, in line with the significant strategic needs of Shanghai and the vigorous national development of antibody and virus vaccine industries. At the end of 2016, the company completed the tasks of the first phase of the project and achieved the expected goals, established a key technological innovation R&D and application service platform for antibody and vaccine biomanufacturing based in Shanghai and serving the whole country, made a breakthrough in personalized serum-free medium production and manufacturing technology, and built a localized pilot system, achieving a double harvest of technological innovation and achievement transformation, and recently passed the acceptance of the project (phase I). On behalf of the company, Mr. Tan expressed his gratitude to Mr. Zhang for his efforts. On behalf of the company, Tan Wensong thanked the management committee of Zhangjiang High-tech Zone and Shanghai Municipal Education Commission for their strong support of the construction of this project and will continue to focus on the innovation and development of key technologies in the next step to give full play to the role of technology leadership. At the same time, the company will build a new platform, improve the service capacity, scale, and level of the existing platform, and vigorously promote the development and localization of relevant key raw materials and equipment, to better support, serve and guarantee the development of biopharmaceutical industries such as antibody and virus vaccine in China.

The picture showed Professor Tan Wensong giving a project report

Afterward, the leaders of the research meeting inspected the R&D service platform and personalized culture medium pilot system of the company. During the investigation, Cao Zhenquan, executive deputy director of Zhangjiang High-tech Zone Management Committee, and Jiang Hong, inspector of Municipal Education Commission, fully affirmed the achievements of the project in terms of scientific and technological innovation and transformation, exploration of mechanism and system, collaborative innovation of industry-university-research-application, and promotion of scientific and technical progress in the industry, and gave a warm discussion on the future development of the company, mechanism and system reform, exploration of equity incentive, the relationship between enterprises and schools, and utilization of external resources. The seminar was held and many pertinent opinions and suggestions were put forward.

Prof. Tan Wensong introduced the personalized culture medium to the leaders

The picture showed the leaders visiting the R&D service platform of the company

The picture showed the leaders' speech